Suppr超能文献

铁氧体增强 MRI 评估在鼠深静脉血栓模型中静脉血栓溶解和巨噬细胞含量。

Ferumoxytol-enhanced MRI assessment of venous Thrombus resolution and macrophage content in a murine deep vein thrombosis model.

机构信息

Department of Surgery, Division of Vascular Surgery, School of Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.

Department of Radiology, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA; Advanced Imaging Research Center (AIRC), Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.

出版信息

Thromb Res. 2024 Aug;240:109063. doi: 10.1016/j.thromres.2024.109063. Epub 2024 Jun 13.

Abstract

BACKGROUND

Imaging evaluation of acute deep vein thrombosis (DVT) or post-thrombotic syndrome (PTS) in animal or clinical models is limited to anatomical assessment of the location and extent of thrombi. We hypothesize that Fe-MRI, used to evaluate macrophage content in other inflammatory diseases, can be useful to evaluate the thromboinflammatory features after DVT over time.

METHODS

Nineteen wild-type CD-1 mice underwent surgical IVC ligation to induce DVT. Mice received either saline or 5 mg/kg of 14E11, a Factor XI inhibitor, before the procedure. Fe-MRI was performed on days 6-7 after ligation to evaluate thrombus volume, perfusion, and macrophage content via T-weighted images. Mice were euthanized at days 3-15 after surgery. The thrombi and adjacent vein walls were excised, weighed, formalin-fixed, and paraffin-embedded for immunohistological analysis. Specimens were stained with specific antibodies to evaluate macrophage content, collagen deposition, neovascularization, and recanalization. Significance was determined using the Mann-Whitney U or Student's t-test.

RESULTS

After IVC-ligation in control mice, thrombus weights decreased by 59 % from day 3 to 15. Thrombus volumes peaked on day 5 before decreasing by 85 % by day 13. FXI inhibition led to reduced macrophage content in both thrombi (p = .008) and vein walls (p = .01), decreased thrombus volume (p = .03), and decreased thrombus mass (p = .01) compared to control mice. CCR2+ staining corroborated these findings, showing significantly reduced macrophage presence in the thrombi (p = .002) and vein wall (p = .002).

CONCLUSIONS

Fe-MRI T relaxation times can be used to characterize and quantify post-thrombotic changes of perfusion, macrophage content, and thrombus volume over time in a surgical mouse model of venous thrombosis. This approach could lead to better quantification of in vivo inflammation correlating monocyte and macrophage content within resolving thrombi and veins and may serve as a useful tool for research and clinically in the evaluation of the post-thrombotic environment.

摘要

背景

在动物或临床模型中,对急性深静脉血栓形成(DVT)或血栓后综合征(PTS)的影像学评估仅限于血栓位置和范围的解剖评估。我们假设,用于评估其他炎症性疾病中巨噬细胞含量的铁磁共振成像(Fe-MRI)可用于随时间推移评估 DVT 后的血栓炎症特征。

方法

19 只野生型 CD-1 小鼠接受外科 IVC 结扎以诱导 DVT。在手术前,小鼠接受生理盐水或 5mg/kg 的 14E11(因子 XI 抑制剂)。在结扎后 6-7 天进行 Fe-MRI,通过 T 加权图像评估血栓体积、灌注和巨噬细胞含量。在手术后 3-15 天处死小鼠。取出血栓和相邻静脉壁,称重,福尔马林固定,石蜡包埋用于免疫组织化学分析。使用特异性抗体对标本进行染色,以评估巨噬细胞含量、胶原沉积、新生血管形成和再通。使用 Mann-Whitney U 或 Student's t 检验确定显著性。

结果

在对照小鼠的 IVC 结扎后,血栓重量在第 3 天至 15 天减少了 59%。血栓体积在第 5 天达到峰值,然后在第 13 天减少 85%。与对照小鼠相比,因子 XI 抑制导致血栓(p=0.008)和静脉壁(p=0.01)中的巨噬细胞含量减少,血栓体积(p=0.03)和血栓质量(p=0.01)减少。CCR2+染色证实了这些发现,显示血栓(p=0.002)和静脉壁(p=0.002)中的巨噬细胞存在明显减少。

结论

Fe-MRI T 弛豫时间可用于在静脉血栓形成的手术小鼠模型中随时间特征化和定量评估灌注、巨噬细胞含量和血栓体积的血栓后变化。这种方法可以更好地量化体内炎症,将单核细胞和巨噬细胞含量与正在溶解的血栓和静脉相关联,并且可能成为评估血栓后环境的研究和临床有用工具。

相似文献

3
Thrombolysis for acute deep vein thrombosis.急性深静脉血栓形成的溶栓治疗
Cochrane Database Syst Rev. 2016 Nov 10;11(11):CD002783. doi: 10.1002/14651858.CD002783.pub4.
4
Home versus in-patient treatment for deep vein thrombosis.深静脉血栓形成的家庭治疗与住院治疗对比
Cochrane Database Syst Rev. 2018 Jan 9;1(1):CD003076. doi: 10.1002/14651858.CD003076.pub3.
7
Antiplatelet agents for the treatment of deep venous thrombosis.抗血小板药物治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD012369. doi: 10.1002/14651858.CD012369.pub2.
8
Pentasaccharides for the treatment of deep vein thrombosis.用于治疗深静脉血栓形成的五糖。
Cochrane Database Syst Rev. 2017 Dec 2;12(12):CD011782. doi: 10.1002/14651858.CD011782.pub2.
9
Angioplasty or stenting for deep venous thrombosis.血管成形术或支架置入术治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011468. doi: 10.1002/14651858.CD011468.pub2.
10
Compression therapy for prevention of post-thrombotic syndrome.用于预防血栓形成后综合征的压迫疗法。
Cochrane Database Syst Rev. 2017 Sep 26;9(9):CD004174. doi: 10.1002/14651858.CD004174.pub3.

本文引用的文献

1
The new in anticoagulation: factor XI inhibitors.抗凝领域的新进展:凝血因子XI抑制剂。
Eur Heart J Suppl. 2023 Apr 21;25(Suppl B):B65-B68. doi: 10.1093/eurheartjsupp/suad070. eCollection 2023 Apr.
6
Molecular and Nonmolecular Imaging of Macrophages in Atherosclerosis.动脉粥样硬化中巨噬细胞的分子与非分子成像
Front Cardiovasc Med. 2021 May 19;8:670639. doi: 10.3389/fcvm.2021.670639. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验